260 related articles for article (PubMed ID: 11842107)
1. The MT domain of the proto-oncoprotein MLL binds to CpG-containing DNA and discriminates against methylation.
Birke M; Schreiner S; García-Cuéllar MP; Mahr K; Titgemeyer F; Slany RK
Nucleic Acids Res; 2002 Feb; 30(4):958-65. PubMed ID: 11842107
[TBL] [Abstract][Full Text] [Related]
2. Binding to nonmethylated CpG DNA is essential for target recognition, transactivation, and myeloid transformation by an MLL oncoprotein.
Ayton PM; Chen EH; Cleary ML
Mol Cell Biol; 2004 Dec; 24(23):10470-8. PubMed ID: 15542854
[TBL] [Abstract][Full Text] [Related]
3. The mixed lineage leukemia (MLL) protein involved in 11q23 translocations contains a domain that binds cruciform DNA and scaffold attachment region (SAR) DNA.
Broeker PL; Harden A; Rowley JD; Zeleznik-Le N
Curr Top Microbiol Immunol; 1996; 211():259-68. PubMed ID: 8585957
[TBL] [Abstract][Full Text] [Related]
4. MLL-AFX requires the transcriptional effector domains of AFX to transform myeloid progenitors and transdominantly interfere with forkhead protein function.
So CW; Cleary ML
Mol Cell Biol; 2002 Sep; 22(18):6542-52. PubMed ID: 12192052
[TBL] [Abstract][Full Text] [Related]
5. MLL repression domain interacts with histone deacetylases, the polycomb group proteins HPC2 and BMI-1, and the corepressor C-terminal-binding protein.
Xia ZB; Anderson M; Diaz MO; Zeleznik-Le NJ
Proc Natl Acad Sci U S A; 2003 Jul; 100(14):8342-7. PubMed ID: 12829790
[TBL] [Abstract][Full Text] [Related]
6. 11q23 translocations split the "AT-hook" cruciform DNA-binding region and the transcriptional repression domain from the activation domain of the mixed-lineage leukemia (MLL) gene.
Zeleznik-Le NJ; Harden AM; Rowley JD
Proc Natl Acad Sci U S A; 1994 Oct; 91(22):10610-4. PubMed ID: 7938000
[TBL] [Abstract][Full Text] [Related]
7. The leukemogenic fusion of MLL with ENL creates a novel transcriptional transactivator.
Schreiner SA; García-Cuéllar MP; Fey GH; Slany RK
Leukemia; 1999 Oct; 13(10):1525-33. PubMed ID: 10516753
[TBL] [Abstract][Full Text] [Related]
8. Functional specificity of CpG DNA-binding CXXC domains in mixed lineage leukemia.
Risner LE; Kuntimaddi A; Lokken AA; Achille NJ; Birch NW; Schoenfelt K; Bushweller JH; Zeleznik-Le NJ
J Biol Chem; 2013 Oct; 288(41):29901-10. PubMed ID: 23990460
[TBL] [Abstract][Full Text] [Related]
9. The ENL moiety of the childhood leukemia-associated MLL-ENL oncoprotein recruits human Polycomb 3.
García-Cuéllar MP; Zilles O; Schreiner SA; Birke M; Winkler TH; Slany RK
Oncogene; 2001 Jan; 20(4):411-9. PubMed ID: 11313972
[TBL] [Abstract][Full Text] [Related]
10. The eleven-nineteen-leukemia protein ENL connects nuclear MLL fusion partners with chromatin.
Zeisig DT; Bittner CB; Zeisig BB; García-Cuéllar MP; Hess JL; Slany RK
Oncogene; 2005 Aug; 24(35):5525-32. PubMed ID: 15856011
[TBL] [Abstract][Full Text] [Related]
11. Dimerization contributes to oncogenic activation of MLL chimeras in acute leukemias.
So CW; Lin M; Ayton PM; Chen EH; Cleary ML
Cancer Cell; 2003 Aug; 4(2):99-110. PubMed ID: 12957285
[TBL] [Abstract][Full Text] [Related]
12. Molecular mechanisms of leukemogenesis mediated by MLL fusion proteins.
Ayton PM; Cleary ML
Oncogene; 2001 Sep; 20(40):5695-707. PubMed ID: 11607819
[TBL] [Abstract][Full Text] [Related]
13. A component of the transcriptional repressor MeCP1 shares a motif with DNA methyltransferase and HRX proteins.
Cross SH; Meehan RR; Nan X; Bird A
Nat Genet; 1997 Jul; 16(3):256-9. PubMed ID: 9207790
[TBL] [Abstract][Full Text] [Related]
14. LCX, leukemia-associated protein with a CXXC domain, is fused to MLL in acute myeloid leukemia with trilineage dysplasia having t(10;11)(q22;q23).
Ono R; Taki T; Taketani T; Taniwaki M; Kobayashi H; Hayashi Y
Cancer Res; 2002 Jul; 62(14):4075-80. PubMed ID: 12124344
[TBL] [Abstract][Full Text] [Related]
15. MLL targets SET domain methyltransferase activity to Hox gene promoters.
Milne TA; Briggs SD; Brock HW; Martin ME; Gibbs D; Allis CD; Hess JL
Mol Cell; 2002 Nov; 10(5):1107-17. PubMed ID: 12453418
[TBL] [Abstract][Full Text] [Related]
16. The small oligomerization domain of gephyrin converts MLL to an oncogene.
Eguchi M; Eguchi-Ishimae M; Greaves M
Blood; 2004 May; 103(10):3876-82. PubMed ID: 14751928
[TBL] [Abstract][Full Text] [Related]
17. AF4p12, a human homologue to the furry gene of Drosophila, as a novel MLL fusion partner.
Hayette S; Cornillet-Lefebvre P; Tigaud I; Struski S; Forissier S; Berchet A; Doll D; Gillot L; Brahim W; Delabesse E; Magaud JP; Rimokh R
Cancer Res; 2005 Aug; 65(15):6521-5. PubMed ID: 16061630
[TBL] [Abstract][Full Text] [Related]
18. Common mechanism for oncogenic activation of MLL by forkhead family proteins.
So CW; Cleary ML
Blood; 2003 Jan; 101(2):633-9. PubMed ID: 12393557
[TBL] [Abstract][Full Text] [Related]
19. The elongation domain of ELL is dispensable but its ELL-associated factor 1 interaction domain is essential for MLL-ELL-induced leukemogenesis.
Luo RT; Lavau C; Du C; Simone F; Polak PE; Kawamata S; Thirman MJ
Mol Cell Biol; 2001 Aug; 21(16):5678-87. PubMed ID: 11463848
[TBL] [Abstract][Full Text] [Related]
20. ENL, the MLL fusion partner in t(11;19), binds to the c-Abl interactor protein 1 (ABI1) that is fused to MLL in t(10;11)+.
García-Cuéllar MP; Schreiner SA; Birke M; Hamacher M; Fey GH; Slany RK
Oncogene; 2000 Mar; 19(14):1744-51. PubMed ID: 10777208
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
